Publication | Closed Access

Effects of levosimendan on circulating pro-inflammatory cytokines and soluble apoptosis mediators in patients with decompensated advanced heart failure

InflammationSoluble Apoptosis MediatorsCardiomyopathyHeart FailureCardiovascular DiseaseDisease PathophysiologyPro-inflammatory CytokinesMedicineCardiovascular PharmacologyCell DeathPharmacologyCardiology